These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7905297)

  • 1. Release of tumor cells from bone marrow.
    Shpall EJ; Jones RB
    Blood; 1994 Feb; 83(3):623-5. PubMed ID: 7905297
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor contamination in stem cell products from patients with neuroblastoma and breast cancer.
    Moss TJ
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S17. PubMed ID: 8899162
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral blood stem cell collection and use in Hodgkin's disease. Comparison with marrow in autologous transplantation.
    Lasky LC; Hurd DD; Smith JA; Haake R
    Transfusion; 1989 May; 29(4):323-7. PubMed ID: 2566209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of bone marrow processing and progenitor cell/mononuclear cell concentrate collection in a continuous flow blood cell separation system.
    Hester JP; Rondón G; Huh YO; Lauppe MJ; Champlin RE; Deisseroth AB
    J Hematother; 1995 Aug; 4(4):299-306. PubMed ID: 7489144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of breast cancer cell detection by immunomagnetic enrichment.
    Krüger W; Tögel F; Rössing S; Kröger N; Zander AR
    Cytotherapy; 1999; 1(2):135-9. PubMed ID: 19746590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of contaminating tumor cells by RT-PCR in breast cancer patients.
    Vannucchi AM; Glinz S; Bosi A; Fallai C; Rossi-Ferrini P
    Bone Marrow Transplant; 1999 Jul; 24(2):228-9. PubMed ID: 10455359
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests.
    Henry JM; Sykes PJ; Brisco MJ; To LB; Juttner CA; Morley AA
    Br J Haematol; 1996 Mar; 92(3):614-9. PubMed ID: 8616025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model system for the enrichment of tumor cells from peripheral blood and bone marrow using immunomagnetic ferrofluids.
    Kemshead JT; Hancock JP; Liberti PA
    Prog Clin Biol Res; 1994; 389():593-600. PubMed ID: 7700925
    [No Abstract]   [Full Text] [Related]  

  • 9. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.
    Brugger W; Bross KJ; Glatt M; Weber F; Mertelsmann R; Kanz L
    Blood; 1994 Feb; 83(3):636-40. PubMed ID: 7507729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells.
    Krüger W; Kröger N; Tögel F; Badbaran A; Renges H; Gieseking F; Gutensohn K; Jänicke F; Zander AR
    J Hematother Stem Cell Res; 2001 Apr; 10(2):303-7. PubMed ID: 11359677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
    Thomson B; Hawkins D; Felgenhauer J; Radich J
    Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
    Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD
    J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood cell transplantation: report from an International Consensus Meeting.
    Juttner CA; Fibbe WE; Nemunaitis J; Kanz L; Gianni AM
    Bone Marrow Transplant; 1994 Nov; 14(5):689-93. PubMed ID: 7889001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR.
    Pfleiderer C; Zoubek A; Gruber B; Kronberger M; Ambros PF; Lion T; Fink FM; Gadner H; Kovar H
    Int J Cancer; 1995 Apr; 64(2):135-9. PubMed ID: 7542227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hematopoietic stem cells: potential use as tumor-free autografts after high-dose myeloablative cancer therapy.
    Hoffman R
    Am J Med Sci; 1995 May; 309(5):254-9. PubMed ID: 7733140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell engraftment.
    Kaur S; Raggatt LJ; Millard SM; Wu AC; Batoon L; Jacobsen RN; Winkler IG; MacDonald KP; Perkins AC; Hume DA; Levesque JP; Pettit AR
    Blood; 2018 Aug; 132(7):735-749. PubMed ID: 29945953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Aging and Hematopoietic Cell Transplantation.
    Cupit-Link MC; Arora M; Wood WA; Hashmi SK
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1965-1970. PubMed ID: 30130587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
    Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization and selection of CD34-positive hematopoietic progenitors.
    Cagnoni PJ; Shpall EJ
    Blood Rev; 1996 Mar; 10(1):1-7. PubMed ID: 8861273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive detection of metastatic tumor cells in bone marrow.
    Moss TJ
    Prog Clin Biol Res; 1994; 389():567-77. PubMed ID: 7700922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.